Works matching IS 13518216 AND DT 2021 AND VI 27 AND IP 5
Results: 38
Preoperative bleeding risk assessment with ISTH‐BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 717, doi. 10.1111/hae.14376
- By:
- Publication type:
- Article
Identification of F8 rearrangements in carrier and non‐carrier mothers of haemophilia A patients.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e654, doi. 10.1111/hae.14394
- By:
- Publication type:
- Article
An exploration of why men with severe haemophilia might not want gene therapy: The exigency study.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 760, doi. 10.1111/hae.14378
- By:
- Publication type:
- Article
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e596, doi. 10.1111/hae.14364
- By:
- Publication type:
- Article
Acquired factor V inhibitor presenting as life threatening bleeding after initiation of apixaban.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e636, doi. 10.1111/hae.14374
- By:
- Publication type:
- Article
Afibrinogenemia with two compound heterozygous mutations in FGA gene.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e641, doi. 10.1111/hae.14377
- By:
- Publication type:
- Article
Quality of periprocedural care in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 830, doi. 10.1111/hae.14389
- By:
- Publication type:
- Article
Quality of life of people with hereditary factor XIII deficiency treated at a reference centre.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e649, doi. 10.1111/hae.14387
- By:
- Publication type:
- Article
Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 769, doi. 10.1111/hae.14383
- By:
- Publication type:
- Article
Deep viral metagenomics in patients with haemophilia receiving plasma‐derived coagulation factor concentrates.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e645, doi. 10.1111/hae.14382
- By:
- Publication type:
- Article
Changes in pain profile of patients with haemophilia during 1‐year follow‐up.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 783, doi. 10.1111/hae.14380
- By:
- Publication type:
- Article
European principles of care for women and girls with inherited bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 837, doi. 10.1111/hae.14379
- By:
- Publication type:
- Article
Validation of the pictorial blood loss assessment chart using modern sanitary products.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e632, doi. 10.1111/hae.14373
- By:
- Publication type:
- Article
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 736, doi. 10.1111/hae.14372
- By:
- Publication type:
- Article
Elective surgery in patients with inherited bleeding disorders: A retrospective analysis.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 744, doi. 10.1111/hae.14365
- By:
- Publication type:
- Article
A full molecular picture of F8 intron 1 inversion created with optical genome mapping.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e638, doi. 10.1111/hae.14375
- By:
- Publication type:
- Article
Intracranial haemorrhage among a population of haemophilic patients in Nepal: Challenges and future direction.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e630, doi. 10.1111/hae.14371
- By:
- Publication type:
- Article
Quantitative measurements of haemophilic joint tissues by point‐of‐care musculoskeletal ultrasound: Associations with clinical and functional joint outcome parameters.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 866, doi. 10.1111/hae.14368
- By:
- Publication type:
- Article
Reply to: Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e628, doi. 10.1111/hae.14367
- By:
- Publication type:
- Article
Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 876, doi. 10.1111/hae.14366
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e609, doi. 10.1111/hae.14370
- By:
- Publication type:
- Article
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 751, doi. 10.1111/hae.14369
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 887, doi. 10.1111/hae.14362
- Publication type:
- Article
What can we expect for adolescents and adults with haemophilia switched to low‐dose prophylaxis from episodic treatment for over 3 years? A real‐world snapshot in China.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e624, doi. 10.1111/hae.14361
- By:
- Publication type:
- Article
Haemophilia Carriers Experience Study (CARES): A mixed method exploration into the experience of women who are carriers of Haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 848, doi. 10.1111/hae.14360
- By:
- Publication type:
- Article
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 730, doi. 10.1111/hae.14359
- By:
- Publication type:
- Article
Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e620, doi. 10.1111/hae.14358
- By:
- Publication type:
- Article
Natural anticoagulants: A missing link in mild to moderate bleeding tendencies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 701, doi. 10.1111/hae.14356
- By:
- Publication type:
- Article
Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 793, doi. 10.1111/hae.14355
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 886, doi. 10.1111/hae.14354
- Publication type:
- Article
Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real‐world cases to support shared decision‐making.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 724, doi. 10.1111/hae.14353
- By:
- Publication type:
- Article
The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 802, doi. 10.1111/hae.14357
- By:
- Publication type:
- Article
Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 823, doi. 10.1111/hae.14352
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. i, doi. 10.1111/hae.14058
- Publication type:
- Article
A survey on practice of circumcision in children with severe haemophilia in Eastern Mediterranean Region.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e617, doi. 10.1111/hae.14351
- By:
- Publication type:
- Article
Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 814, doi. 10.1111/hae.14350
- By:
- Publication type:
- Article
Use of electronic self‐administered bleeding assessment tool in diagnosis of paediatric bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 710, doi. 10.1111/hae.14349
- By:
- Publication type:
- Article